Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (7): 653-658.doi: 10.3969/j.issn.1000-6621.2021.07.003
Previous Articles Next Articles
QI Xue, WU Xi-rong, GUO Ya-jie, WANG Yong-hong, MA Qi, CHEN Yu-ying, SUN Lin(), SHEN A-dong()
Received:
2021-01-31
Online:
2021-07-10
Published:
2021-07-09
Contact:
SUN Lin,SHEN A-dong
E-mail:chinatka@163.com;shenad16@hotmail.com
QI Xue, WU Xi-rong, GUO Ya-jie, WANG Yong-hong, MA Qi, CHEN Yu-ying, SUN Lin, SHEN A-dong. Analysis of screening of latent tuberculosis infection in hospitalized children[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 653-658. doi: 10.3969/j.issn.1000-6621.2021.07.003
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.07.003
临床特征 | 呼吸系统疾病 | 泌尿系统疾病 | 风湿免疫系统疾病 | 血液系统/肿瘤疾病 | 合计 |
---|---|---|---|---|---|
性别 | |||||
男性 | 4615(60.34) | 1370(67.19) | 3343(53.79) | 1901(59.57) | 11229(58.81) |
女性 | 3033(39.66) | 669(32.81) | 2872(46.21) | 1290(40.43) | 7864(41.19) |
年龄组(岁) | |||||
<5 | 4285(56.03) | 787(38.60) | 896(14.42) | 1956(61.30) | 7924(41.50) |
≥5 | 3363(43.97) | 1252(61.40) | 5319(85.58) | 1235(38.70) | 11169(58.50) |
卡痕 | |||||
有 | 7245(94.73) | 1968(96.52) | 5756(92.61) | 3112(97.52) | 18081(94.70) |
无 | 403(5.27) | 71(3.48) | 459(7.39) | 79(2.48) | 1012(5.30) |
肺结核接触史 | |||||
有 | 237(3.10) | 32(1.57) | 105(1.69) | 40(1.25) | 414(2.17) |
无 | 7411(96.90) | 2007(98.43) | 6110(98.31) | 3151(98.75) | 18679(97.83) |
应用激素或免疫抑制剂 | |||||
是 | 411(5.37) | 317(15.55) | 905(14.56) | 377(11.81) | 2010(10.53) |
否 | 7237(94.63) | 1722(84.45) | 5310(85.44) | 2814(88.19) | 17083(89.47) |
合计 | 7648(40.06) | 2039(10.68) | 6215(32.55) | 3191(16.71) | 19093(100.00) |
影响因素 | TST(+)/IGRA(+)和 TST(-)/IGRA(-) | TST(+)/IGRA(-)和 TST(-)/IGRA(+) | χ2值 | P值 |
---|---|---|---|---|
性别 | 0.591 | 0.442 | ||
男性 | 7298(96.46) | 268(3.54) | ||
女性 | 5191(96.20) | 205(3.80) | ||
年龄组(岁) | 17.460 | <0.01 | ||
<5 | 4860(97.22) | 139(2.78) | ||
≥5 | 7629(95.81) | 334(4.19) | ||
卡痕 | 2.906 | 0.088 | ||
有 | 11785(96.28) | 455(3.72) | ||
无 | 704(97.51) | 18(2.49) | ||
肺结核接触史 | 14.215 | <0.01 | ||
有 | 293(92.43) | 24(7.57) | ||
无 | 12196(96.45) | 449(3.55) |
[1] | World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization, 2015. |
[2] |
Venturini E, Tersigni C, Chiappini E, et al. Optimizing the management of children with latent tuberculosis infection. Expert Rev Anti Infect Ther, 2017, 15(4):341-349. doi: 10.1080/14787210.2017.1279541.
doi: 10.1080/14787210.2017.1279541 pmid: 28074660 |
[3] | World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management: annex 3: values and preferences for the management of latent tuberculosis infection: survey of populations affected by the recommendations. Geneva: World Health Organization, 2018. |
[4] | World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization, 2014. |
[5] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[6] |
孙琳, 田建岭, 尹青琴, 等. γ干扰素释放试验在不同年龄活动性结核病患儿诊断中的应用价值. 中国防痨杂志, 2015, 37(7):757-763. doi: 10.3969/j.issn.1000-6621.2015.07.009.
doi: 10.3969/j.issn.1000-6621.2015.07.009 |
[7] |
Sloot R, Schim van der Loeff MF, Kouw PM, et al. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med, 2014, 190(9):1044-1052. doi: 10.1164/rccm.201406-1159OC.
doi: 10.1164/rccm.201406-1159OC URL |
[8] |
Davies HD, Committee on Infectious Diseases. Infectious complications with the use of biologic response modifiers in infants and children. Pediatrics, 2016, 138(2):e20161209. doi: 10.1542/peds.2016-1209.
doi: 10.1542/peds.2016-1209 URL |
[9] |
黄安芳, 罗妍, 赵毅, 等. 风湿病患者合并潜伏性结核感染的分析. 中华内科杂志, 2016, 55(4):307-310. doi: 10.3760/cma.j.issn.0578-1426.2016.04.012.
doi: 10.3760/cma.j.issn.0578-1426.2016.04.012 |
[10] |
Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis, 2017, 64(2):111-115. doi: 10.1093/cid/ciw778.
doi: 10.1093/cid/ciw778 pmid: 28052967 |
[11] |
Campbell JR, Chen W, Johnston J, et al. Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis. Mol Diagn Ther, 2015, 19(2):107-117. doi: 10.1007/s40291-015-0135-6.
doi: 10.1007/s40291-015-0135-6 URL |
[12] |
Starke JR, Committee on Infectious Diseases. Interferon-gamma release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics, 2014, 134(6):e1763-1773. doi: 10.1542/peds.2014-2983.
doi: 10.1542/peds.2014-2983 URL |
[13] |
Xin H, Zhang H, Yang S, et al. 5-Year follow-up of active tuberculosis development from latent Infection in rural China. Clin Infect Dis, 2020, 70(5):947-950. doi: 10.1093/cid/ciz581.
doi: 10.1093/cid/ciz581 |
[14] |
Sargın G, Şentürk T, Ceylan E, et al. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy. Tuberk Toraks, 2018, 66(2):136-143. doi: 10.5578/tt.66444.
doi: 10.5578/tt.66444 URL |
[15] |
Edwards A, Gao Y, Allan RN, et al. Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis. Thoras, 2017, 72(10):946-949. doi: 10.1136/thoraxjnl-2016-209397.
doi: 10.1136/thoraxjnl-2016-209397 |
[16] |
Sun L, Tian JL, Yin QQ, et al. Performance of the interferon gamma release assays in tuberculosis disease in children five years old or less. PLoS One, 2015, 10(12):e0143820. doi: 10.1371/journal.pone.0143820.
doi: 10.1371/journal.pone.0143820 URL |
[17] |
高磊, 权竹声, 成君, 等. 结核分枝杆菌感染检测两步法在学校结核病控制工作中的应用探讨. 中华预防医学杂志, 2020, 54(4):385-391. doi: 10.3760/cma.j.cn112150-20191204-00909.
doi: 10.3760/cma.j.cn112150-20191204-00909 |
[1] | YANG Ting-ting, GAO Qian. The tuberculosis drug-resistance and transmission surveillance network based on whole genome sequencing data [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 645-648. |
[2] | ZHAO Guo-lian, TAN Xiao-wen, CUI Xiao-li, DANG Li-yun. Analysis of gene polymorphism of Mycobacterium tuberculosis with negative MPT64 antigen in culture filtrate [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 659-663. |
[3] | YI Jun-li, YANG Xin-yu, CHEN Hao, ZHAO Yan-feng, CHEN Shuang-shuang, ZHANG Jie, DING Bei-chuan, DAI Xiao-wei, SUN Shan-hua, WU Wen-qing, LI Chuan-you. Analysis of drug resistance of 1156 clinical isolates of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 677-681. |
[4] | YAO Rong, LU Yu. Research and progress of early bactericidal activity of anti-tuberculosis drugs [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 724-728. |
[5] | WANG Qian, HE Jin-ge, LI Yu-hong, CHEN Ming-ting, ZHOU Lin. A study on the effect of artificial intelligence automatic film reading technology in active tuberculosis screening of HIV/AIDS population [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 557-561. |
[6] | ZHANG Lei, LI Yuan-yuan, CHEN Xi, LIU Hai-ting, XU Jian, WANG Ning, DING Yang-ming, LU Yu. Study of the mechanism of the new antidrug-resistant tuberculosis drug pyrifazimine mediated by quinone oxidoreductase [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 576-583. |
[7] | FANG Min, SHI Yan, DUAN Li, SHI Xiao-mei, QUAN Shu-ting, WANG Ya-cui, PENG Xiao-shan, JIA Ji-hang, QI Hui, JIAO Wei-wei, ZHU Yu, SUN Lin. Diagnostic value of GeneXpert MTB/RIF Ultra for pulmonary tuberculosis in children using gastric juice [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 584-589. |
[8] | LUO Dan, QIN Hui-fang, YE Jing, ZHAO Jin-ming, QIN Yi-xiang, LAN Ru-shu. Analysis on gene mutation characteristics of drug resistant Mycobacterium tuberculosis and its correlation with genotypes in Guangxi [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 596-601. |
[9] | WU Tuo-ya, SHI Jin, GUO Ji-dong, LIU Yuan-yuan, PANG Yu, LU Jie, GAO Fei. Mechanism of miR-21-3p modulating the survival of Mycobacterium tuberculosis in host macrophage [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 475-481. |
[10] | WANG Lu, XUE Zhong-tan, WANG Yu-feng, SHANG Yuan-yuan, REN Wei-cong, YAO Cong, GAO Fei, PANG Yu. A study of dynamic monitoring of drug sensitivity of Mycobacterium tuberculosis to bedaquiline and the mechanism of drug resistance [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 482-486. |
[11] | ZHANG Li-jie*, HAN Xi-qin, WANG Jing-ping, CHEN Yu-hui, CHEN Sheng-yu, CHEN Ling, LI Bo, LIN Ming-gui, LI You-lun, SHI Lian, XI Xiu-e, MA Li-ping, WANG Xin, WANG Fei, ZHAO Cai-yan, WANG Fu-rong, CHEN Sen-lin, WU Xiang, LI Po, ZHANG Peng, LENG Xue-yan, ZHANG Hai-qing, CAO Wen-li, SHU Wei, SUN Yu-xian, XIE Shi-heng, TIAN Xi-zhong, HUANG Xue-rui, DU Jian, GAO Wei-wei. The relationship between bacterial load and treatment failure and recurrence of sputum positive retreatment pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 335-340. |
[12] | LIU Ting*, WANG Liang, YANG Mei. The study on the anti-tuberculosis activity of polymorphonuclear cell from peripheral blood of patients with multidrug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 352-356. |
[13] | ZHANG Chen-chen*, TAN Wei-guo, GUO Hui-xin, HUANG Xin-chun, CHEN Yan-mei, WEI Wen-jing. The effect of Mycobacterium tuberculosis infection on sputum flora structure [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 357-363. |
[14] | BAI Hua, GUO Jing-wei, HU Pei-lei, YI Song-lin, WEN Jia, LIU Feng-ping, TAN Yun-hong, BAI Li-qiong. Analysis of drug resistance surveillance results of Mycobacterium tuberculosis in Hu’nan Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 364-369. |
[15] | HE Yi-jun, ZHANG Hao-ran, XIN He-nan, GAO Lei. Optimizing the application of tuberculin skin test [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 204-210. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||